This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Nurix Therapeutics, Inc.. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Aileen Kelly: Innovator in Biopharmaceuticals
Introduction
Aileen Kelly is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of biopharmaceuticals, particularly in the development of compounds that target specific pathways in disease treatment. Her innovative work has garnered attention in the scientific community.
Latest Patents
Aileen Kelly holds 1 patent for her invention titled "Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway." This patent relates to compounds that are useful for degrading BTK through a ubiquitin proteolytic pathway. The disclosure also includes pharmaceutically acceptable compositions comprising these compounds and methods for using them in the treatment of various diseases, conditions, or disorders.
Career Highlights
Aileen is currently employed at Nurix Therapeutics, Inc., where she continues to advance her research and development efforts. Her work at Nurix Therapeutics focuses on innovative therapeutic solutions that address unmet medical needs.
Collaborations
Aileen collaborates with notable professionals in her field, including her coworker Arthur T. Sands. Their combined expertise contributes to the advancement of biopharmaceutical research and development.
Conclusion
Aileen Kelly's contributions to the field of biopharmaceuticals exemplify her dedication to innovation and improving patient outcomes. Her work continues to inspire future advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile